Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06086756 · ClinicalTrials.gov registry record · NA
Virtual Reality Intervention for Speech Anxiety
A NA study of Public Speaking and Speech Anxiety, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT06086756 is a NA study of Public Speaking and Speech Anxiety that has completed, run by Boston University Charles River Campus. The registered enrollment target is 48 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06086756, a NA study of Public Speaking and Speech Anxiety, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.
Conditions Studied
Interventions
- BEHAVIORAL Exposure intervention plus positive mood induction
- BEHAVIORAL Exposure intervention plus negative mood induction
Study Locations (1)
Massachusetts
- Center for Anxiety and Related Disorders - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2023-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06086756
The ClinicalTrials.gov registry entry for NCT06086756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Public Speaking appearing as the primary indexed condition, and to 2 interventions - of which Exposure intervention plus positive mood induction is the first listed.
NCT06086756 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06086756 about?
NCT06086756 is a clinical study titled "Virtual Reality Intervention for Speech Anxiety". Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present study is designed to evaluate whether mood state moderates outcome to a brief VR exposure intervention.
What is the current status of trial NCT06086756?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2023-11-01. Estimated completion is 2023-12-05.
What conditions does trial NCT06086756 study?
This clinical trial studies the following conditions: Public Speaking, Speech Anxiety.
What interventions are being tested in trial NCT06086756?
The interventions under investigation include: Exposure intervention plus positive mood induction (BEHAVIORAL), Exposure intervention plus negative mood induction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06086756?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06086756 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.